Purity: | USP 35 |
---|---|
Model Number: | 145040-37-5 |
Brand Name: | Tianrui |
Grade Standard: | Medicine Grade |
Type: | Anti-hypertensive |
Place of Origin: | China (Mainland) |
MF: | C33H34N6O6 |
CAS No.: | 145040-37-5 |
MW: 610.66: | Appearance: White to off-white crystalline powder |
Quick Details
Specifications
Candesartan Cilexetil Anti Hypertensive Drugs CAS No.145040-37-5
Quick Details:
Product Name: Trityl Candesartan Cilexetil
CAS No.: 145040-37-5
MF: C33H34N6O6
MW: 610.66
Specification: CP, USP
Appearance: White to off-white crystalline powder.
Usage: Ester prodrug; hydrolized in vivo to the active carboxylic acid. Used in Treatment of congestive heart failure. Antihypertensive.
Description:
Candesartan Cilexetil is a synthetic, Benzimidazole-derived angiotensin II receptor antagonist prodrug with Antihypertensive activity. after hydrolysis of candesartan cilexetil to Candesartan during gastrointestinal absorption, candesartan selectively Competes with angiotensin II for the binding of the angiotensin II receptor Subtype 1 (AT1) in vascular smooth muscle, blocking angiotensin II-mediated Vasoconstriction and inducing vasodilatation. In addition, antagonism of AT1 in The adrenal gland inhibits angiotensin II-stimulated aldosterone synthesis and Secretion by the adrenal cortex; sodium and water excretion increase, followed by a reduction in plasma volume and blood pressure.
Patent
Disclaimer:
1. Products protected by valid patents are not offered for sale in
Jurisdictions where the sale of such products constitutes a patent
Infringement. the current list only reflects the products and technologies that
Are available, under development: note that some products may be developed or
Produced for internal and experimental uses with no commercal aim.
2. Sales of products are limited to those allowed by Chapter VII PLPRC 63, the
above includes Research and development quantities.
3. R&D use in accordance with (1) 35 USC 271(e)+A13(1) in the U.S.; (2)
Section 69.1 of Japanese Patent Law in Japan; (3) Section 11, No. 2 of the
German Patent Act of 1981 in Germany; (IV) Section 60, Paragraph 5b of the U.K.
Patents Act of 1977 in the U.K.; (4) Sections 55.2(1) and 55.2(6) and other
Common law exemptions of Canadian patent law; (5) Section 68B of the Patents
Act of 1953 in New Zealand together with the amendment of same by the Statutes
Amendment Bill of 2002; (6) such related legislation and/or case law as may be
Or become applicable in the aforementioned countries; and (7) such similar laws
And rules as may apply in various other countries.
Specification:
Appearance | White to off white powder | Conforms | |
Solubility | Slightly soluble in Methanol,practically insoluble in water. | Conforms | |
Identification | IR spectrum matches reference spectrum | Conforms
| |
the retention time of the major peak obtained in the related Substances corresponds to that of the reference | |||
Water | ≤0.3% | 0.1% | |
Residue on Ignition |
≤0.1% |
<0.1% | |
Heavy Metals |
≤0.001% |
<0.001% | |
Related Substances (HPLC) | |||
Impurity A |
≤0.2% |
0.03% | |
Impurity B |
≤0.3% |
0.03% | |
Impurity E |
≤0.2% |
0.06% | |
Any other unknown impurity |
≤0.1% |
<LOQ | |
Total impurities |
≤0.6% |
0.15% | |
Residual solvents by GC | |||
Acetone |
≤5000ppm |
N.D | |
Hexane |
≤290ppm |
N.D | |
Acetonitrile |
≤410ppm |
N.D | |
Methanol |
≤3000ppm |
N.D. | |
Dichloromethane |
≤600ppm |
125pm | |
Ethanol |
≤5000ppm |
N.D | |
Assay (by Titration) |
98.7-101.0%(calculated on anhydrous basis) |
99.6% | |
Conclusion | COMPLES with USP35 | ||
Our Advantages
1,High quality
with competitive price:
1)Standard:USP
2)All Purity≥99%
3)We are manufacturer and can provide high quality products with factory price.
2,Fast and safe
Delivery
1)Parcel can be sent out in 24 hours after payment.
2)Secure and discreet shipment.Various transportation methods for your choice.
3)Effective after-sale service
4)Tracking your order at any time. Inform your order's Further new situation at any time.